New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
14:38 EDTAKRXAkorn expects U.S. FDA inspection of India site by late 2015, early 2016
As a first step, we have implemented Akorn's global quality policies at the Akorn India site. We are now in the process of implementing our plan to transfer existing or file new products to trigger U.S. FDA facility inspections by late 2013 or early 2014. The proposed oncology facility and expanded injectable facility should be completed by late 2014, and we expect the U.S. FDA to inspect these facilities by late 2015 or early 2016.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
17:55 EDTAKRXRepligen to replace Hi-Tech Pharmacal in S&P 600 as of 4/17
Subscribe for More Information
April 14, 2014
19:01 EDTAKRXAkorn gets FTC clearance for Hi-Tech Pharmacal deal
Akorn (AKRX) announced that the U.S. FTC has voted to approve Akornís acquisition of Hi-Tech Pharmacal (HITK). The unanimous vote in support of the transactions follows Akornís agreement to a proposed consent order requiring divestiture of certain products as a condition to obtaining FTC approval. The parties have now obtained all regulatory approvals required to consummate the acquisition, and intend to close by the end of this week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use